Department of Medicine, Center of Excellence in Arrhythmia Research Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok 10330 Thailand.
Department of Medicine, Center of Excellence in Arrhythmia Research Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok 10330 Thailand; Bumrungrad Hospital, Bangkok and Pacific Rim Electrophysiology Research Institute, Bangkok, Thailand; Las Vegas, NV, USA.
Card Electrophysiol Clin. 2022 Dec;14(4):685-692. doi: 10.1016/j.ccep.2022.08.006.
Three decades have passed since the Brugada syndrome (BrS) clinical entity was introduced in the early 1990s. During the first 2 decades, treatment of patients with BrS was challenging because there were limited treatment options, and an implantable cardioverter-defibrillator was the only choice for high-risk patients with BrS, that is, those who had aborted sudden cardiac death or had previous ventricular fibrillation episodes. In this article, the authors focus on these advances and how to treat patients with BrS with catheter ablation.
自 20 世纪 90 年代初 Brugada 综合征（BrS）临床实体被引入以来，已经过去了三十年。在最初的 20 年里，BrS 患者的治疗极具挑战性，因为治疗选择有限，对于 BrS 高危患者，即那些曾发生过心源性猝死或有过室颤发作的患者，植入式心脏复律除颤器是唯一的选择。本文作者重点介绍了这些进展以及如何使用导管消融治疗 BrS 患者。
